+ All Categories
Home > Documents > Chronic Fatigue and Kindling

Chronic Fatigue and Kindling

Date post: 07-Apr-2018
Category:
Upload: joehague
View: 221 times
Download: 0 times
Share this document with a friend

of 24

Transcript
  • 8/3/2019 Chronic Fatigue and Kindling

    1/24

    Kindling and Oxidative Stress as Contributors to Myalgic

    Encephalomyelitis/Chronic Fatigue Syndrome

    L. A. Jason1,*, N. Porter1, J. Herrington1, M. Sorenson1, and S. Kubow2

    1 DePaul University

    2 McGill University

    Abstract

    Myalgic Encephalomyelitis/chronic fatigue syndrome (ME/CFS) is one of the more complex

    illnesses involving multiple systems within the body. Onset of ME/CFS frequently occurs quickly,

    and many patients report a prior exposure to a viral infection. This debilitating illness can affect

    the immune, neuroendocrine, autonomic, and neurologic systems. Abnormal biological findings

    among some patients have included aberrant ion transport and ion channel activity, cortisol

    deficiency, sympathetic nervous system hyperactivity, EEG spike waves, left ventricular

    dysfunction in the heart, low natural killer cell cytotoxicity, and a shift from Th1 to Th2 cytokines.

    We propose that the kindling and oxidative stress theories provide a heuristic template for better

    understanding the at times conflicting findings regarding the etiology and pathophysiology of this

    illness.

    Keywords

    Myalgic Encephalomyelitis; Chronic Fatigue Syndrome; Kindling; Oxidative Stress

    Chronic fatigue syndrome (CFS), also known as Myalgic Encephalomyelitis or Myalgic

    Encephalopathy (ME), is a highly incapacitating illness with an annual value of lost

    productivity in the USA estimated to be $9.1 billion (Reynolds, Vernon, Bouchery, &

    Reeves, 2004). Moreover, total direct and indirect costs due to Myalgic Encephalomyelitis/

    chronic fatigue syndrome (ME/CFS) ranges from $19 to $24 billion (Jason, Benton,

    Johnson, & Valentine, 2008). Patients with ME/CFS are more functionally impaired than

    those suffering from type II diabetes mellitus, congestive heart failure, multiple sclerosis,

    and end-stage renal disease (Anderson & Ferrans, 1997; Buchwald, Pearlman, Umali,

    Schmaling, & Katon, 1996). Andersson and Ferrans found that the scores for quality of life

    were lower for ME/CFS than any other chronic illness group. It is estimated that over

    800,000 individuals have this illness in the USA (Jason et al., 1999). Given the prevalence

    and impact of this illness on patients, there is a need to identify theoretical frameworks for

    better understanding the etiology and pathophysiology of this complex illness. Below, we

    review two promising theories involving kindling and oxidative stress.

    2009 The College of Saint Rose* Corresponding Author: DePaul University Center for Community Research 990 W. Fullerton Avenue Chicago, IL [email protected] .

    NIH Public AccessAuthor ManuscriptJ Behav Neurosci Res. Author manuscript; available in PMC 2011 January 18.

    Published in final edited form as:

    J Behav Neurosci Res. 2009 January 1; 7(2): 117.

    NIH-PAAu

    thorManuscript

    NIH-PAAuthorManuscript

    NIH-PAAuthorM

    anuscript

  • 8/3/2019 Chronic Fatigue and Kindling

    2/24

    Kindling Theory

    According to the kindling theory, repeated exposure to an initially subthreshold stimulus can

    eventually exceed threshold limits, resulting in persistent hypersensitivity to the stimulus

    and ultimately, spontaneous behavioral manifestations. Kindling among patients with ME/

    CFS might appear after prolonged stimulation of the limbic-hypothalamic-pituitary axis,

    either by high-intensity stimulation (e.g., brain trauma) or by chronically repeated low-

    intensity stimulation (e.g., an infectious illness). In support of kindling theory, patients withME/CFS often report prior exposure to a viral infection. Viruses increase activation of

    macrophages, which produce a release of interleukin-1beta, causing an alteration in the

    electrical activity of the brain (Maier, Watkins, & Fleshner, 1994).

    Kindling was first discovered by Goddard (1967) while studying the effects of electrical

    stimulation of the amygdaloid complex on learning. Initially, he electrically stimulated

    brains of rats at a very low intensity, which was below the threshold for eliciting seizure

    activity. When this stimulation was applied over a period of weeks, the rats experienced

    epileptic convulsions. In other words, after repeated exposure to small electric shocks, the

    rats began to have spontaneous seizure-like electrical events. Goddard and others also found

    it was possible to induce kindling via chemical stimulation. Evidence indicates that kindling

    involves afterdischarge of cell populations that continue to fire after the initiating

    stimulation has ceased (Loescher & Ebert, 1996). The stimulus is followed by a growingEEG 3Hz spiking, which increases and decreases in amplitude many times. At times the 3Hz

    spiking can vanish, only to return seconds later. This seizure activity often spreads to

    adjacent structures in the brain.

    Gellhorn (1970) postulated that under prolonged stimulation of the limbic-hypothalamic-

    pituitary axis, a lowered threshold for activation can occur. Once this system is charged,

    either by high-intensity stimulation (e.g., due to an acute viral infection) or by chronically

    repeated low-intensity stimulation (e.g., through repeated chemical exposure), it can sustain

    a high level of arousal with little or no external stimulus. Girdano, Everly, and Dusek (1990)

    suggest that the excessive arousal can lead to an increase in the dendrites of the limbic

    system, which can further increase limbic stimulation. The limbic system might sprout more

    excitatory postsynaptic receptors and decrease its inhibitory presynaptic receptors.

    Subsequently, people with kindling may experience excitatory neurotoxicity. Brouwer andPacker (1994) have conducted research indicating that people with ME/CFS might have

    unstable cortical excitability associated with sustained muscle activity resulting in varied

    magnitudes of descending volleys (p. 1212). This is an indication that kindling might be

    occurring within the brains of patients with ME/CFS.

    Two receptors residing on the cell surface membranes of neurons are GABA (gamma

    aminobutyric acid), which inhibits neuronal firing, and NMDA (N-methyl-D-aspartate),

    which excites neuronal firing. The GABA and NMDA receptors should be balanced, but

    after an injury or viral attack, NMDA fires more than GABA. Minor and Hunter (2002) have

    proposed that prolonged exposure to inescapable stressors will eventually deplete GABA,

    thus reducing an important form of inhibition on excitatory glutamate transmission. Doi,

    Ueda, Nagatomo, and Willmore (2009) studied hippocampal glutamate and GABA

    transporters (i.e., GLAST, GLT-1, and EAAC1) by injecting rats three times a week withpentylenetetrazol, which can induce kindling. Levels of EAAC1 and GAT-1 in easily-

    kindled rats were decreased by 30% compared to levels in rats that were resistant to being

    kindled. This suggests that decreased EAAC1 and GAT-1, which diminish GABA function,

    are associated with the convulsive threshold at the beginning of kindling development.

    Jason et al. Page 2

    J Behav Neurosci Res. Author manuscript; available in PMC 2011 January 18.

    NIH-PAA

    uthorManuscript

    NIH-PAAuthorManuscript

    NIH-PAAuthor

    Manuscript

  • 8/3/2019 Chronic Fatigue and Kindling

    3/24

    The importance of GABA to sleep difficulties, one of the primary problems of patients with

    ME/CFS, was highlighted in a recent study by Winkelman et al. (2008). This research team

    found brain GABA levels were nearly 30% lower in patients with primary insomnia and

    GABA levels were negatively correlated with wake after sleep onset. Recent findings

    indicate that the glial cell or astrocyte produces adenosine, which appears to be implicated in

    controlling wake to sleep transitions (Halassa et al., 2009). In response to cellular damage

    such as inflammation, concentrations of adenosine become quickly elevated from 300 nM to

    up to 600-1,200 nM, which probably promotes sleep and rest. When levels of adenosineincrease, brain nerve impulses are suppressed. High adenosine levels can suppress epileptic

    seizures, and it appears that adenosine acts through the A1 receptor to produce sleep

    pressure. The adenosine A(2A) receptor (A(2A)R) plays a crucial role in the regulation of

    sleep, and in rats, Hong et al. (2005) found the A(2A)R agonist induced sleep by inhibiting

    the histaminergic system through increasing GABA release. It is possible that kindling could

    also result in low levels of adenosine over time, and thus the development of sleep

    difficulties. It should be noted that adenosine is only one of many substances that promotes

    sleep, and others include tumor necrosis factor, interleukin-1, interleukin-6, and growth

    releasing hormone, whereas sleep-inhibiting substances include corticotropin releasing

    hormone, substance P, and interleukin-10 (Krueger, 2009).

    Ultimately, chronic stress sensitizes neural processes and this over-activation might lead to

    fatigue. The limbic system plays a regulatory role pertaining to symptoms of fatigue, pain,memory, and cognition. In part, it plays this role with the use of dopamine to inhibit NMDA

    receptor-mediated nociception (Wood et al., 2007). Chronic stress has been shown to

    attenuate dopaminergic activity (Wood, 2004), and this disruption in dopamine function

    might also lead to some of the cognitive dysfunction experienced by many ME/CFS patients

    (Nieoullon, 2002). It should be noted that one study did not find abnormalities in regional

    amino acid neurotransmitter function in patients with ME/CFS (Mathew et al., 2009).

    Kindling can develop through a number of ways for patients with ME/CFS. Zalcman,

    Savina, and Wise (1999) have found that immunogenic stimuli can alter brain circuitry,

    changing its sensitivity to seemingly unrelated subsequent stimuli. In addition, stress might

    be a conditioned stimulus that leads to an impaired immune response (Gupta, 2002).

    Exposure to stress can induce long-term potentiation, such that the brain cells react more

    strongly in response to future exposures to a drug or stress (Saal et al., 2003).

    Secondary lesions can also occur in the brain, which are not located at the site of the original

    kindling. These secondary sites are exposed to cortical excitability through normal synaptic

    pathways and intercellular communication. Therefore, different regions of the brain may

    become kindled in a secondary manner, separate from the initial kindling. These secondary

    sites could then affect different organ systems in a top-down fashion, leading to the diverse

    symptom patters found in patients with ME/CFS.

    Gupta (2002), borrowing on the work from LeDoux (1996), has suggested that an infection,

    chemical or physiological stressor can act to create a cell assembly within the unconscious

    amygdala, which can create sympathetic stimulation through the hypothalamus and other

    brain pathways involving the flight or fight response. The amygdala first determines whether

    a stimuli poses a threat, and if so, then the amygdala initiates autonomic and endocrineresponses to help the organism survive. Areas of the prefrontal cortex and anterior cingulate

    (which will be referred to below) are involved in attention to dangerous or negative stimuli,

    which ultimately influence the amygdala. In long-term potentiation, synaptic strength does

    increase between co-firing neurons after brief but repetitive stimulation, and this has many

    similarities to kindling. LeDoux (1996) refers to these cell assemblies as being particularly

    resistant to extinction; so for some patients this hard-wiring may only be regulated rather

    Jason et al. Page 3

    J Behav Neurosci Res. Author manuscript; available in PMC 2011 January 18.

    NIH-PAA

    uthorManuscript

    NIH-PAAuthorManuscript

    NIH-PAAuthor

    Manuscript

  • 8/3/2019 Chronic Fatigue and Kindling

    4/24

    than extinguished. Gupta (2002) believes that activation of the amygdala causes continuous

    sympathetic stimulation that is a predominantly unconscious process over which patients

    have little control, but it eventually leads to mental and physical exhaustion as well as

    glandular depletion. Wyller, Eriksen, and Malterud (2009) proposed compatible theories that

    sustained arousal is the primary mechanism of CFS, and they also reviewed findings on how

    arousal responses can be modified by sensitization.

    This kindling theory has been used to explain secondary generalized temporal lobe epilepsy,and Bell et al. (1997) have reviewed evidence that kindling is implicated in multiple

    chemical sensitivity disorders. This kindling theory could be extended to help explain the

    etiology of ME/CFS.

    Oxidative Stress Theory

    Martin Pall (2007) has suggested that oxidative stress might help explain the

    pathophysiology among patients with ME/CFS. According to Palls theory, when NMDA

    receptors on neurons are activated by a virus, bacteria, mold, toxin, microbe or allergy, they

    trigger nitric oxide production. In addition, the mitochondria in cells take in oxygen and

    nutrition and output carbon dioxide, water and ATP (energy). For every molecule of ATP

    generated, one molecule of superoxide is generated. The superoxide in the mitochondria

    sometimes leaks out, where it combines with nitric oxide. One molecule of nitric oxide

    combines with one molecule of superoxide to make one molecule of peroxynitrite.

    Peroxynitrite will break down to release hydroxyl radical, and that will cause genetic

    damage. Peroxynitrite and free radical formulation has been implicated in coronary artery

    disease, cancer, Parkinsons and Alzheimers diseases, Multiple Sclerosis (MS), and

    autoimmune diseases. Peroxynitrite also acts to increase levels of both nitric oxide and

    superoxide, which then produce more peroxynitrite; thus producing a self-sustaining cycle.

    The enzyme superoxide dismutase, embedded in the mitochondria, can break superoxide

    down to hydrogen peroxide and then to water to prevent superoxide from leaking out of

    mitochondria, but this enzyme cannot do its job without proper amounts of selenium and

    glutathione (and the latter is depleted in patients with CFS, Van Konynenburg, 2007).

    During sleep, the brain produces more superoxide dismutase, and this works to neutralize

    the free radicals that have been generated during the day due to metabolism.

    It is of interest that many patients with ME/CFS report that Coenzyme Q10 (CoQ10),

    Klonopin, and Neurontin are helpful in reducing symptoms. CoQ10 binds to excess

    superoxide so that it cannot couple with nitric oxide to produce peroxynitrite. Also of

    interest, Klonopin and Neurontin upregulates GABA and down regulates NMDA, which

    reduces nitric oxide. Women are reported to produce more nitric oxide than men (Forte et al.

    1998), possibly contributing to the gender bias seen in ME/CFS. These findings support

    Palls (2007) theory, and suggest that oxidative stress might play an important role in ME/

    CFS. Kindling might be the mechanism to elicit excessive arousal and excitatory

    neurotoxicity, whereas oxidative stress might represent the end result of this kindling. If

    structural changes in the neurons have occurred, with a growth in excitatory postsynaptic

    receptors and a decrease in inhibitory presynaptic receptors, then it might be extremely

    difficult to recover from such an illness, which is confirmed by outcome studies indicating a

    poor prognosis for adult patients with ME/CFS (Friedberg & Jason, 1998).

    There are several studies that have been published suggesting that oxidative stress does

    occur in patients with ME/CFS. For example, Kennedy et al. (2005) found that patients with

    ME/CFS had significantly increased levels of isoprostanes, and among patients who were

    not obese or hypertensive, ME/CFS symptoms correlated with isoprostane levels. In the

    group of normotensive and nonobese patients with ME/CFS, antioxidant activity, as

    Jason et al. Page 4

    J Behav Neurosci Res. Author manuscript; available in PMC 2011 January 18.

    NIH-PAA

    uthorManuscript

    NIH-PAAuthorManuscript

    NIH-PAAuthor

    Manuscript

  • 8/3/2019 Chronic Fatigue and Kindling

    5/24

    measured by glutathione levels, was not reduced. This supports an interpretation that

    oxidative stress is due to excessive free radical formation and not depleted antioxidant

    reserves. Robinson et al. (2009) investigated the levels of IL-6, its soluble receptors (sIL-6R

    and sgp130) and F(2)-isoprostanes, at rest and during exercise, and they found that F(2)-

    isoprostanes were higher in CFS patients at rest and at 24 hours post-exercise.

    Several animal studies have also provided supportive evidence. Kumar, Garg, and Kumar

    (2008) found that forced swimming for 7 days caused a chronic fatigue-like condition andoxidative damage in mice. Trazodone was administered each day 30 minutes before the

    forced swim test, and this pretreatment attenuated the oxidative damage. However, when L-

    arginine (a NO precursor) was administered 15 minutes before administration of trazodone,

    the L-arginine reversed the protective effect of trazodone. This study suggests involvement

    of the nitric oxide pathway in the neuroprotective potential of trazodone in a mouse model

    of ME/CFS. In another animal model, Gupta et al. (2009) found significant oxidative stress

    after immunological activation, and an antioxidant called curcumin significantly reduced

    both oxidative stress and serum tumor necrosis factor-alpha. Finally, Lyle et al. (2009)

    forced rats to swim in water for 15 minutes per day on 21 consecutive days, which lead to

    oxidative stress. Nardostachys jatamansi extract (NJE) given orally had an antioxidant effect

    as it tended to normalize augmented lipid peroxidation, nitrite, superoxide dismutase

    activities and catalase level.

    In the sections below, we will examine how the kindling and oxidative stress theories might

    be helpful in better understanding findings from different domains within the ME/CFS

    literature.

    Genetics

    Gow et al. (2005) reported gene expression data suggesting that ME/CFS may involve ion

    transport and ion channel activity, which is necessary for the generation of action potentials

    and the release of neurotransmitters at synaptic terminals. Muscle fatigue and post-

    exertional malaise may relate to a shift of membrane hypopolarization potential (Chaudhuri,

    Behan, & Behan, 2005). Sustained changes in cell membrane function may follow exposure

    to infections and neurotoxins as when ciguatera toxin irreversibly inactivates sodium

    channels in an open mode, and these can cause delayed symptoms of chronic fatigue.Whistler, Jones, Unger, and Vernon (2005) examined differences in gene expression before

    and after exercise for those with ME/CFS and matched controls. They also found differences

    in ion transport and ion channel activity at baseline, and these differences were exaggerated

    after exercise. Saiki et al. (2008) in a study of CFS associated markers, used quantitative

    real-time polymerase chain reaction to validate nine genes encoding granzyme in activated T

    or natural killer cells (GZMA), energy regulators (ATP5J2, COX5B, and DBI), proteasome

    subunits (PSMA3 and PSMA4), putative protein kinase c inhibitor (HINT), GTPase

    (ARHC), and signal transducers and activators of transcription 5A (STAT5A).

    Discrepant findings have occurred in the gene studies, and Light, White, Hughen, and Light

    (2009) suggest that this is due to the fact that it is only with exercise that reliable gene

    differences emerge between controls and patients, and the studies above did not employ an

    exercise challenge. In selecting genes to examine before and after exercise challenges, it iscritical to focus on genes that contribute to the primary symptoms of CFS including fatigue,

    postexertional malaise, and muscle pain. Light et al. (2008) conducted mouse experiments

    and identified two classes of sensory neurons that were capable of sending signals

    interpreted as physical fatigue and muscle pain. They found the following molecular

    receptors detected the metabolites produced by muscle contraction: an acid sensing ion

    channel (also called amiloride sensitive ion channel) or ASIC (ASIC3), 2 Purinergic X type

    Jason et al. Page 5

    J Behav Neurosci Res. Author manuscript; available in PMC 2011 January 18.

    NIH-PAA

    uthorManuscript

    NIH-PAAuthorManuscript

    NIH-PAAuthor

    Manuscript

  • 8/3/2019 Chronic Fatigue and Kindling

    6/24

    receptors (P2X5 and/or P2X4), and transient receptor potential vanilloid type 1 (TRPV1).

    Based on this mouse model, Light et al. (2008) suggested that increased expression of these

    molecular receptors encoding metabolites could be a marker of enhanced fatigue and/or

    muscle pain.

    Light and colleagues (2009) also maintain that genes from the sympathetic nervous system

    have also been implicated in CFS. In response to the metabolite buildup in working muscles,

    the sympathetic nervous system regulates regional blood flow (e.g., b-Adrenergic receptorsplay a major role in maintaining sufficient blood flow to skeletal muscles during exercise

    preventing excessive accumulation of metabolites). In addition, genes from the immune

    system have also been implicated in CFS. Moving from animal models to studies with

    normal humans, Light and colleagues found that mRNA for metabolite detecting (ASIC3,

    P2X4, P2X5, TRPV1), sympathetic nervous system (adrenergic a-2A, b-1, and b-2, as well

    as COMT), and immune (IL6, IL10, TNF-a, TLR4, CD14) were upregulated after strenuous

    exercise (Light et al., 2007). In a later study, Light et al. (2009) examined patients with CFS

    versus controls after exercise. Light et al. found patients with CFS demonstrated increases

    after exercise that reliably exceeded responses of control subjects in mRNA for genes that

    can detect increases in muscle produced metabolites (ASIC3, P2X4, P2X5), genes that are

    essential for sympathetic nervous system processes (adrenergic a-2A, b-1, and b-2, as well

    as COMT), and immune function genes (IL10, and TLR4). Of interest, at baseline before the

    exercise challenge, there were no significant differences between the CFS and controlgroups. Significant correlations were found between post exercise physical and mental

    fatigue and increases in mRNA of the genes. Finally, approximately 90% of the CFS

    patients could be distinguished from control subjects using just 4 of the genes measured (i.e.,

    P2X4, adrenergic b-1, adrenergic b-2, IL10). Light et al. (2009) concluded that ME/CFS

    patients might have enhanced sensory signal for fatigue that is increased after exercise.

    These findings all indicate persistent changes in cell membrane function, which are

    compatible with a kindling theory.

    The situation might even be more complicated, as Kerr et al. (2008) clustered quantitative

    polymerase chain reaction data from patients with ME/CFS and found seven subtypes with

    distinct differences in clinical phenotypes. Still, these data do implicate a number of genes

    that are related to oxidative stress and changes in ion transport and ion channel activity that

    might be affected by kindling.

    Infectious Factors

    The onset of ME/CFS has sometimes been linked with the presence of an infection. For

    example, some cases of ME/CFS have been reported as following acute mononucleosis,

    Lyme disease, and Q fever (Komaroff, 2000). Certain viruses [e.g., HSV-1, HHV-6, Epstein

    Barr virus (EBV), and cytomegalovirus] may influence the relapsing and remitting

    pathogenesis of ME/CFS (Englebienne & Meirleir, 2002). Lombardi et al. (2009) identified

    xenobiotic murine retrovirus (XMRV), a gammaretrovirus associated with a subset of

    prostate cancer, in the blood of 67% of ME/CFS patients but only 3.7% in controls.

    Retroviruses like XMRV activate a number of other latent viruses like the EBV, and this

    could explain why so many different viruses have been associated with ME/CFS.

    Neurotropic viral infections that replicate within and subsequently damage the centralnervous system could be responsible for the appearance of lesions and the presence of focal

    epileptiform seizure activity in an ME/CFS viral onset subgroup. Magnetic resonance (MR)

    studies of encephalopathy and encephalomyelitis associated with acute EBV infection have

    found T2 prolongation over gray and white matter, brain atrophy, and periventricular

    leukomalacia (Shian & Chi, 1996). A MR study examining a pediatric population of patients

    suffering from chronic EBV infection has shown evidence for the presence of lesions in the

    Jason et al. Page 6

    J Behav Neurosci Res. Author manuscript; available in PMC 2011 January 18.

    NIH-PAA

    uthorManuscript

    NIH-PAAuthorManuscript

    NIH-PAAuthor

    Manuscript

  • 8/3/2019 Chronic Fatigue and Kindling

    7/24

    hippocampal region (Hausler et al. 2002). In some cases, cortical lesions caused by herpes

    viridae infections fade before MR documentation can take place. Lesions can then reappear

    under specific conditions of environmental stimuli, a process that fits well with the relapsing

    and remitting hypothesis of ME/CFS.

    Hickie et al. (2006) followed up with people who had cases of mononucleosis (glandular

    fever), Q fever, and Ross River virus, respectively, who later met the criteria for ME/CFS.

    The authors found that the percentage who went on to have ME/CFS was the same for thethree infectious diseases (11% at 6 months), suggesting that the reason these people develop

    ME/CFS is not associated with the particular pathogen, but rather with their host response.

    The syndrome was predicted largely by the severity of the acute illness rather than by

    demographic, psychological, or microbiological factors. In other words, it is the severity of

    the host response that determines the injury, and this would also be compatible with a

    kindling explanation. In the same cohort study, Vollmer-Conna et al. (2008) later found that

    individuals with high levels of IFN gamma and low levels of IL10 were significantly more

    likely to experience severe acute illness following infection and were more likely to be

    symptomatic for a longer time. IFN gamma is one of several pro-inflammatory cytokines,

    and IL10 is one of several anti-inflammatory cytokines.

    White (2007) summarized findings from five cohort studies involving postinfectious illness.

    These studies indicate that a postinfectious fatigue syndrome does exist, and that it is not amood disorder. It appears that there are two postinfectious fatigue syndromes, one

    characterized by excessive sleep and the other by insomnia associated with muscle and joint

    pain. The risk of prolonged fatigue or ME/CFS following postinfectious fatigue syndromes

    is five to six times that of common upper respiratory tract infections, and there is a 10-12%

    risk of ME/CFS six months after infectious onset. Wessely et al. (1995) found that some

    people with ME/CFS had viral infections, while others had other medical illnesses, before

    they developed ME/CFS. Therefore, a viral infection probably represents only one of several

    possible routes to the development of ME/CFS. Kindling theory would also support the

    notion that a variety of stressors (e.g., viruses, chemicals, injury) can lower the threshold for

    activation, which would foster more excitatory postsynaptic receptors and decrease

    inhibitory presynaptic receptors.

    Immune SystemThe bodys reaction to one or more bacterial or viral invaders might induce symptoms in

    patients with ME/CFS. For example, activation by macrophages due to a virus or bacteria

    produces a release of interleukin-1beta, which causes an alteration in the electrical activity

    of the brain and a number of behavioral changes (e.g., decreases in activity and social

    interaction, somnolence) designed to reduce unnecessary energy expenditure, so that

    available energy stores can be used to fight the infection (Maier, Watkins, & Fleshner,

    1994). These electrical changes in the brain can cause kindling.

    Sheng, Hu, Ding, Chao, and Peterson (2001) injected an immunological stimulus that

    elicited a sustained upregulation of cytokines in the cerebral cortex and subcortical

    structures in a mouse; this coincided with marked reduction in running distance for two

    weeks. In humans, Vollmer-Conna et al. (2004) have found that the production of pro-inflammatory cytokines (IL-1b and IL6) was correlated with acute sickness behavior (i.e.,

    fever, malaise, pain, fatigue, and poor concentration). Prolonged exposure to these cytokines

    might induce a state of chronic activation, which may lead to a depletion of the stress

    hormone axis and to other neuroendocrine features associated with ME/CFS. Under these

    circumstances, viruses and bacteria that had previously been contained and controlled by the

    immune system might begin to replicate and ultimately cause symptoms for the patient.

    Jason et al. Page 7

    J Behav Neurosci Res. Author manuscript; available in PMC 2011 January 18.

    NIH-PAA

    uthorManuscript

    NIH-PAAuthorManuscript

    NIH-PAAuthor

    Manuscript

  • 8/3/2019 Chronic Fatigue and Kindling

    8/24

    Many patients with ME/CFS appear to have two basic problems with immune function: a)

    poor cellular function, with low natural killer cell cytotoxicity and frequent immunoglobulin

    deficiencies (most often IgG1 and IgG3), and b) elevations of activated T lymphocytes,

    including cytotoxic T cells, and elevations of circulating cytokines (Evengard, Schachterle,

    & Komaroff, 1999; Patarca-Montero, Mark, Fletcher, & Klimas, 2000). Several researchers

    have found a shift from Th1 to Th2 cytokines among patients with ME/CFS (Antoni et al.,

    2003; Skowera et al., 2004). In the Th1 response, the T-helper cell produces pro-

    inflammatory cytokines, which activate T-cytotoxic cells as well as natural killer cells(Segerstrom & Miller, 2004), and contribute to clearance of intracellular pathogens. In

    contrast, the Th2 pathway involves major anti-inflammatory cytokines, which promote

    humoral immunity by differentiation of B cells into antibody-secreting B cells and B cell

    immunoglobulin switching to IgE. These anti-inflammatory cytokines inhibit production of

    pro-inflammatory cytokine and T-cell proliferation. Whereas a highly anti-inflammatory

    response minimizes inflammation, it can allow existing intracellular infections to linger. Of

    interest is the above mentioned finding by Vollmer-Conna et al. (2008), where those with

    high levels of a pro-inflammatory cytokine (IFN gamma) were significantly more likely to

    experience severe acute illness following infection.

    The administration of a pro-inflammatory cytokine (Tumor Necrosis Factor-alpha) not only

    increases seizure activity in an animal kindling model, it may also potentiate the

    development of future activity (Shandra et al., 2002). Kindling and related seizure activity inanimal models is associated with increased signal transcription and production of pro-

    inflammatory proteins within the brain (Plata-Salaman et al, 2000). Kindling then not only

    potentiates the production of pro-inflammatory mediators which can then contribute to the

    development of lesion, it is in turn influenced by them.

    Borish et al. (1998) found evidence of low level inflammation, similar to that found in

    allergies, in a subgroup of individuals with ME/CFS. Borish et al. suggested that there might

    be two subgroups of individuals with ME/CFS, those with immune activation (infectious or

    inflammatory) and those devoid of immune activation, with other illness processes. It is

    possible that there are two groups of people with ME/CFS, those with kindling and oxidative

    stress and those without it, and that these might correspond to the two groups identified by

    Borish et al. (i.e., those with and without immune activation, respectively). Cook, Lange,

    DeLuca, and Natelson (2001) found that individuals with an abnormal MRI and ongoinginflammatory processes scored significantly worse on measures of physical disability. These

    findings support the idea that there might be important subtypes among patients with ME/

    CFS (Corradi, Jason, & Torres-Harding, 2006). It is at least possible that centrally mediated

    kindling and oxidative stress might lead to different types of immune, autonomic, or

    neuroendocrine dysfunction in different patients.

    Neuroendocrinology

    According to Baram and Hatalski (1998) summarize data indicating that considerable in

    vitro and in vivo data suggest that corticotropin-releasing hormone (CRH) induces neuronal

    excitability, which can lead to epileptic output. Within seconds of exposure to stress, CRH ,

    located in the peptidergic neurons in the paraventricular hypothalamic nucleus (PVN), is

    released from nerve terminals to influence hormonal secretion from ACTH in the pituitaryand glucocorticoid secretions in the adrenal. This is the mechanism by which fevers and

    trauma can activate CRH receptors in the hippocampus and amygdala to induce seizures

    among children and rats. CRH increases the frequency of spontaneous excitatory

    postsynaptic currents by 252% (Baram & Hatalski, 1998). Administration of CRH in rats

    produces seizures in the amygdala and epileptiform discharges in the hippocampus but the

    earliest CRH induced epileptiform discharges are produced in the amydgala and propagate

    Jason et al. Page 8

    J Behav Neurosci Res. Author manuscript; available in PMC 2011 January 18.

    NIH-PAA

    uthorManuscript

    NIH-PAAuthorManuscript

    NIH-PAAuthor

    Manuscript

  • 8/3/2019 Chronic Fatigue and Kindling

    9/24

    to the hippocampus. There might also be a reciprocal relationship as limbic seizure kindling

    results in increased levels of CRH in the hippocampus (Heinrichs & Koob, 2004). Once the

    kindling has occurred, the CRH might play a less critical role in maintaining the kindling,

    and after time, CRH levels might even become depleted.

    Scott and Dinan (1999) found that patients with ME/CFS tend to have a reduced adrenal

    secretory reserve and smaller adrenal glands when compared to healthy subjects; in contrast

    to major depression, enlarged adrenal glands are found. Altemus et al. (2001) found thatpatients with ME/CFS had a reduced ACTH response and a more rapid cortisol response to a

    vasopressin infusion, which suggests reduced hypothalamic CRH secretion. Glucocorticoids

    can have an inhibitory effect on serotonin function, and CRH release is modulated by

    serotonin. In addition, the increased prolactin response to fenfluramine is due to elevated

    activity of presynaptic serotonin neurons (Vassallo et al., 2001). This might be the region

    affected by kindling, and several other studies have also found evidence of increased

    serotonergic activity in patients with ME/CFS (Bakheit et al, 1992; Cleare et al., 1995;

    Demitrack et al., 1992; Sharpe et al., 1997). One pilot study found that medications that

    block serotonin (5-HT3) receptors were followed by at least a 35% improvement in about

    one-third of patients (Spath et al., 2000). Still, there may be subtypes of patients, as one

    study found decreased brain serotonin levels in patients with ME/CFS (Badawy et al., 2005).

    In addition, there are eight different Serotonin receptors, and this might explain differential

    outcomes of Serotnin altering therapies.

    Neuroendocrine dysfunction in ME/CFS involve hypocortisolism and increased serotonin

    neurotransmitter function, whereas in depression, hypercortisolism and decreased serotonin

    neurotransmitter function have been found (Cleare et al., 1995). Also of interest are the

    findings that four minutes after a maximal treadmill exercise test for patients with ME/CFS,

    stress responsive hormones (adrenocorticotropin, catecholamines, prolactin) were at less

    than half the level of controls (Ottenweller, LaManca, Sisto, Guo & Natelson, 1997).

    When stress occurs for weeks or months, and glucocorticoid levels are maintained at a high

    level for long periods of time, the immune system is suppressed. In addition to the

    suppression of inflammation by long term stress, the Th1 immune response is also

    suppressed. The immune response is then shifted to a Th2 immune response mechanism.

    Clauw and Chrousos (1997) suggest that individuals who develop ME/CFS may begenetically predisposed to development of the condition, and that hormonal changes in

    people with ME/CFS are primary, while immune changes are secondary. Clauw and

    Chrousos suggest that once the individual develops ME/CFS, which can occur abruptly or

    slowly through viral infections or emotional stressors, there is a blunting of the human stress

    response.

    Chaudhuri and Behan (2004) speculate that there might be different neuroendocrine

    processes in subgroups of individuals that ultimately lead to chronic fatigue. For example,

    enhanced negative feedback of the HPA axis could account for alterations in HPA

    functioning in patients with ME/CFS. Fries, Hesse, Hellhammer, and Hellhammer (2005)

    suggest that an increased sensitivity to the negative feedback of circulating corticosterone

    contributes to the hyporeactive HPA axis under stressful conditions. In other words, they

    suggest enhanced pituitary feedback is the primary mechanism underlying thehypocortisolemic stress response. Increased sensitivity of lymphocytes to glucocorticoids

    might lead to the Th2 shift previously found in ME/CFS patients (Skowera et al., 2004).

    Kindling might also account for this increased sensitivity.

    Ben-Zvi, Vernon, and Broderick (2009) posit that chronic stress will lead to depressed

    cortisol concentrations, and when stress is removed, the cortisol will stay at this depressed

    Jason et al. Page 9

    J Behav Neurosci Res. Author manuscript; available in PMC 2011 January 18.

    NIH-PAA

    uthorManuscript

    NIH-PAAuthorManuscript

    NIH-PAAuthor

    Manuscript

  • 8/3/2019 Chronic Fatigue and Kindling

    10/24

    value. Glucocorticoids exert negative feedback at the hypothalamus and pituitary to inhibit

    secretion of CRH and ACTH. However, glucocorticoid negative feedback causes a reduction

    in corticotroph receptor expression, which leads to a desensitization of the pituitary to the

    stimulatory effect of CRH on ACTH release. Ben-Zvi et al. suggest that if cortisol is

    reduced, it will force a buildup of ACTH, and when ACTH increases about 30% above

    baseline, the bodys own natural feedback control will restore cortisol levels to normal.

    However, if kindling is the mechanism for the reduction of cortisol, such a strategy is

    unlikely to be effective.

    Oxidative stress is linked with glucocorticoid resistance by affecting several aspects of

    glucocorticoid receptor (GR) activation and function including reduced GR nuclear transport

    (Okamoto et al., 1999), reduced GR transcription via decreases in histone deacetylase C2

    (HDAC2) activity (Adcock et al., 2005), and decreased expression of glucocorticoid

    regulatory genes. HDAC2 activity, which is important in GR function, is decreased by

    tyrosine nitration leading to reduced steroid sensitivity. Antioxidant treatment partially

    restores dexamethasone sensitivity in reactive oxygen species (ROS)-exposed cells by

    increasing HDAC activity (Ito et al., 2001). Several redox-sensitive transcription factors that

    are activated by intracellular oxidative stress attenuate GR function in steroid resistant states

    (Marshall et al., 2000). For instance, ROS activate nuclear factor kB (Mercurio & Manning,

    1999), which interferes with GR expression and function (Nissen & Yamamoto, 2000) and

    has been indicated as a possible mediator between psychosocial and oxidative stress(Bierhaus et al., 2003). Induction of oxidative stress involving genes and signaling

    molecules such as stress-activated protein kinases and heat shock proteins is associated with

    stress-related disorders (Schett et al., 2001). Conversely, epigenetic changes resulting from

    interventions involving meditative practices and the relaxation response lead to increased

    gene expression of glutathione S-transferase, increased intracellular levels of glutathione and

    heat shock protein 70 and enhanced activity of glutathione peroxidase and superoxide

    dismutase (Dusek et al., 2008; Sharma et al., 2008). These latter interventions are also linked

    with improvements in the pituitary-adrenal activity that could be mediated by an improved

    sensitivity of GR, which is very susceptible to changes in redox status.

    When a person with a certain genetic makeup is subjected to long term stressors, the HPA

    axis and sympathetic nervous system become upregulated. Kindling might represent the

    mechanism for this upregulation. Elevated secretions of glucocorticoids and catecholamines(adrenalin and noradrenalin) may subsequently cause a Th1 to Th2 immune response shift.

    Because of the shift to Th2, the body does not have an effective defense against viral or

    intracellular bacterial infections (e.g., the Epstein Barr virus can become active and produce

    infections). Van Houdenhove, Van Den Eede, and Luyten (2009) suggest that at an early

    stage of the illness, a switch takes place from HPA axis hyper- to hypo-functioning, and this

    observation is supported by some animal and human data. When the HPA axis becomes

    downregulated, there is still not an effective Th1 response to attack viral infections,

    however, now the immune system may cause inflammation (explaining elevated antinuclear

    antibody levels). The patient with ME/CFS now has ineffective protection from viruses,

    intracellular bacteria, and inflammation (Van Konynenburg, 2003). In a review article, Van

    Den Eede, Moorkens, Van Houdenhove, Cosyns, and Claes (2007) concluded that even if

    the HPA axis dysfunction is not the primary factor, it is probably a relevant factor in ME/

    CFS symptom propagation. Kindling and oxidative stress could also help explain thesefindings, as the areas of the brain where the kindling occurs could determine what aspect of

    the HPA system is implicated in the disorder.

    Jason et al. Page 10

    J Behav Neurosci Res. Author manuscript; available in PMC 2011 January 18.

    NIH-PAA

    uthorManuscript

    NIH-PAAuthorManuscript

    NIH-PAAuthor

    Manuscript

  • 8/3/2019 Chronic Fatigue and Kindling

    11/24

    Autonomic Nervous System

    Acetylcholine is a primary neurotransmitter of the parasympathetic nervous system and is

    widely distributed throughout the brain and spinal cord. Chaudhuri, Majeed, Dinan, and

    Behan (1997) believe that ME/CFS entails a depletion of acetylcholine and increased

    sensitivity of the post-synaptic acetylcholine receptors. This could cause sympathetic

    nervous system hyperactivity, which may decrease serum cortisol and may be the common

    denominator for low levels of DHEA in both inflammatory and non-inflammatory diseases(Kizildere, Gluck, Zietz, Scholmerich, & Straub, 2003). Norepinephrine and epinephrine

    inhibit the production of type 1/proinflammatory cytokines, whereas they stimulate the

    production of type 2/anti-inflammatory cytokines. This causes a selective suppression of

    Th1 responses and cellular immunity and a Th2 shift toward dominance of humoral

    immunity (Elenkov, Wilder, Chrousos, & Vizi, 2000). Again, neural kindling might be

    implicated in the depletion of this acetylcholine and increased sensitivity of the post-

    synaptic acetylcholine receptors.

    Other aspects of the circulatory system also seem to be involved in ME/CFS. In response to

    postural stress, 81% of patients with ME/CFS and no controls experienced ejection fraction

    decreases, suggesting left ventricular dysfunction in the heart. Those who had greater

    ejection fraction decreases experienced more severe ME/CFS symptoms in their daily lives

    (Peckerman, Chemitiganti, et al., 2003). Patients with ME/CFS might have lower cardiacoutput. The resulting low flow circulatory state may make it difficult for patients to meet the

    demands of everyday activity and lead to fatigue or other symptoms (Peckerman, LaManca,

    et al., 2003). In addition, Streeten and Bell (2000) found that the majority of patients with

    ME/CFS had striking decreases in circulating blood volume, which might be implicated in

    orthostatic hypotension. Additionally, it appears that the blood vessels in patients with ME/

    CFS are constricted dramatically. The heart and circulatory systems response to standing

    upright is under the control of the sympathetic nervous system (Van Konynenburg, 2003),

    which appears to be overactive in patients with ME/CFS. Pall (2007) suggests that lowered

    cortisol levels can produce cardiac dysfunction, and that lowered cortisol production during

    and following exercise may be implicated in the cardiac dysfunction seen in many patients.

    Kindling could also be implicated in the overactive sympathetic nervous system.

    Many patients with ME/CFS have co-morbid Fibromyalgia, and this latter disorder mightalso be associated with autonomic nervous system problems. Martinez-Lavin and Solano

    (2009) speculate that within the dorsal root ganglia, after a trauma or inflammation due to

    infection, sympathetic neurons sprout and connect to pain sensing neurons, and the dorsal

    root ganglia become hyperexcitable to painful inputs. It is interesting to note how kindling

    might also be involved in this process involving widespread pain.

    Neurology

    Gray and Robinson (2007) have studied brain networks using a physiological-based model

    of the brains electrical activity. They contend that a steady state of electrical activity in the

    brain is present in the absence of stimuli. A stimulus will change this activity, and if the

    brain is stable, when the stimulus is removed the electrical activity will return to a steady

    state. However, the same stimulus in an unstable brain will lead to a continual increase inelectrical activity that can result in neurological disorders.

    Tanaka and Watanabe (2007) used animal models to suggest that initially, in an acutely

    stressed stage, the serotonin and dopamine systems are activated in the central nervous

    system, however, in the later stage of severe fatigue, reduced neuronal activities and energy

    utilization induced by prolonged deprivation of rest elicit central fatigue and insufficient

    activation of these systems in the brain. This is a complex model and implicates infectious

    Jason et al. Page 11

    J Behav Neurosci Res. Author manuscript; available in PMC 2011 January 18.

    NIH-PAA

    uthorManuscript

    NIH-PAAuthorManuscript

    NIH-PAAuthor

    Manuscript

  • 8/3/2019 Chronic Fatigue and Kindling

    12/24

    antecedents for the ultimate damage occurring in the brain, although evidence reviewed

    earlier suggests that infectious agents might be just one of many precipitators of kindling.

    Kuratsune and Watanabe (2007) believe that brain dysfunction among patients with ME/

    CFS is caused by abnormal production of cytokines, which may be caused by reactivation of

    various herpes viral infections and/or chronic mycoplasma infection. Increases in

    transforming growth factor- (TGF- ) have been observed during infection and stress in

    rats (Inoue & Fushiki, 2007). The increase in TGF- inhibits the production of DHEA-S,which is related to the dysmetabolism of acetyl-L-carnitine, leading to deterioration of

    biosynthesis of glutamate in the anterior cingulum. This might cause autonomic imbalance

    and prolonged fatigue. Also, reactivation of various viruses can cause abnormal production

    of IFN-gamma in the brain, leading to elevations of 5-HTT mRNA. This can cause 5-HT

    deficiency in the synapses, leading to fatigue, pain, and depression. Abnormal production of

    IFN-gamma also triggers elevation of 2,5-oligoadenylate synthetase activity which leads to

    an abnormality of RNase-L pathway and CNS dysfunction. Oxidative stress may also be

    implicated in these processes.

    Fatigue is also one of the more frequent symptoms of Multiple Sclerosis (MS). In a sample

    of patients with MS, Sepulcre et al. (2009) found that fatigue was associated with a

    disruption of brain networks involved in cognitive/attentional processes. More specifically,

    fatigue correlated with lesions in the right parietotemporal (periatrial area, juxtaventricularwhite matter deep in the parietal lobe and callosal forceps) and left frontal (middle-anterior

    corpus callosum, anterior cingulum and centrum semiovale of the superior and middle

    frontal gyri) white matter regions. In addition, fatigue scores significantly correlated with

    gray matter atrophy in frontal regions, specifically, the left superior frontal gyrus and

    bilateral middle frontal gyri.

    Cook et al. (2001) found individuals with CFS had a larger number of brain abnormalities

    than healthy controls, and Lange et al. (1999) also report small, punctuate, subcortical white

    matter hyperintersities in the frontal lobes. Johnson and DeLuca (2005) summarized

    structural neuroimaging studies (MRI) and concluded that abnormalities among patients

    with ME/CFS have been inconsistent, but when they have been observed, they have been in

    the subcortical white matter (punctate areas of high signal intensity). Higher abnormalities

    appear to occur among patients with ME/CFS who do not have concurrent psychopathology,versus those who have concurrent psychopathology (Lange et al., 1999).

    Tirelli et al. (1998) documented glucose hypometabolism in the frontal cortex and brain

    stem. Siessmeier et al. (2003) evaluated cerebral glucose metabolism (using 18-

    fluorodeoxyglucose positron emission tomography). Abnormalities were detectable in

    approximately half the patients with ME/CFS, and consistent with other research on

    infectious encephalitis due to multiple types of viruses, no specific pattern could be

    identified (some had hypometabolism bilaterally in the cingulate gyrus and the adjacent

    mesial cortical areas, decreased metabolism in the orbitofrontal cortex, or hypometabolism

    in the cuneus/praecuneus). Nestadt et al. (2007) found that those with ME/CFS had

    ventricular lactate levels that were elevated compared to those with Generalized Anxiety

    Disorder and healthy controls. This suggests mitochondria dysfunction and/or anaerobic

    energy conversion in the brain. Nitric oxide regulates mitochondrial respiration and cellfunction by inhibiting cytochrome oxidase, and mouse models suggest that mitochondria

    dysfunction may be a mechanism by which kindling and oxidative stress are virally

    mediated, causing post infectious break down of the blood brain barrier (Komatsu et al.,

    1999). In anaerobic energy conversion, lactic acid is produced by the cells as they use

    glucose for energy in the absence of adequate oxygen. Yamamoto et al., (2004) using PET,

    found that the density of the 5-HTT of the rostral subdivision of the anterior cingulate cortex

    Jason et al. Page 12

    J Behav Neurosci Res. Author manuscript; available in PMC 2011 January 18.

    NIH-PAA

    uthorManuscript

    NIH-PAAuthorManuscript

    NIH-PAAuthor

    Manuscript

  • 8/3/2019 Chronic Fatigue and Kindling

    13/24

    was significantly reduced in patients with ME/CFS. These findings suggest that an alteration

    in the serotoninergic neurons in the anterior cingulate cortex might play a role in the

    pathophysiology of ME/CFS. Cleare, Messa, Rabiner, and Grasby (2005) found widespread

    reduction in 5-HT(1A) receptor binding potential, and this was particularly marked in the

    hippocampus bilaterally, where a 23% reduction was observed. Cook, OConnor, Lange,

    and Steffener (2007) found that participants with ME/CFS did not differ from controls for

    either finger tapping or auditory monitoring tasks, but exhibited significantly greater activity

    in several cortical and subcortical regions during a fatiguing cognitive task. Morespecifically, mental fatigue was significantly related to brain activity during the fatiguing

    cognitive task, and significant positive relationships were found for cerebellar, temporal,

    cingulate and frontal regions, while a significant negative relationship was found for the left

    posterior parietal cortex. De Lange et al. (2005) observed significant reductions in grey

    matter volume in patients with ME/CFS. Johnson and DeLuca (2005) concluded that

    functional neuroimaging studies among patients with ME/CFS generally show

    hypometabolism in the frontal lobes and ganglia. Clearly, both kindling and oxidative stress

    could be implicated in these findings. Abnormal findings in different regions of the brain

    may be due to kindling that occurs in a secondary manner, separate from the initial kindling.

    These secondary sites could then affect different parts of the brain.

    Caseras et al. (2008) had patients with ME/CFS and healthy controls imagine fatigue-

    provoking events. Using fMRI, larger observed activity was found in the medial parietalcortex and precuneus in patients with ME/CFS compared with healthy controls during the

    fatigue-provocation task than a control task. De Lange, Knoop, Bleijenberg, and van der

    Meer (2008) suggest that larger activity in the precuneus may reflect the more vivid

    capability to imagine oneself in a fatiguing situation. Caseras et al. also found that lower

    cerebral activity was found in the dorsolateral prefrontal cortex, and this is the cortical area

    where Okada et al. (2004) have found reductions of grey matter among patients with ME/

    CFS. According to de Lange et al. (2008), the dorsolateral prefrontal cortex is essential for

    selecting and initiating behavior, and lesions in the lateral prefrontal cortex can reduce

    appropriate goal-directed voluntary behavior. Also of interest, de Lange et al. (2008) found

    that cognitive behavioral therapy could partly reverse the grey matter volume reduction in

    the lateral prefrontal cortex.

    Billiot, Budzynski, and Andrasik (1997) found increased microvolt levels in lowerfrequencies (5-7 Hz) among patients with ME/CFS, and they suggested that the display of

    excess theta waves could be related to cognitive problems. Delta waves occurs from 0 to 4

    Hz, theta from 4 to 8 Hz, alpha from 8 to 13 Hz and beta from 13 to 21 Hz. Peak alpha is the

    Hz value within the range of 8-12 Hz at which the most energy is generated. Theta-to-beta

    ratios were also calculated. The expected difference in the alpha range (8-12 Hz) was not

    found, but when counting backwards from 900 by 7s, the EEG microvolt activity was

    actually significantly lower than the non-patient comparison group. Research using low-

    resolution electromagnetic brain tomography by Sherlin et al. (2006) has found that twins

    with ME/CFS compared to their healthy co-twins had higher delta waves in the left uncus

    and parahippocampal gyrus and higher theta waves in the cingulate gyrus and right superior

    frontal gyrus. It appears that slowing of the deeper structures of the limbic system is

    associated with affect.

    Donati, Fagioli, Komaroff, and Duffy (1994) examined quantified EEG (qEEG) data, which

    included standard EEGs and long latency evoked potentials (EP) with individuals diagnosed

    ME/CFS. Among 44% of the patients with ME/CFS, spike waves were observed compared

    to only 1.3% of all others (i.e., patients with depression who were medicated, patients with

    depression who were not medicated, as well as healthy controls). Spikes were most common

    in the temporal regions. Those in the ME/CFS group also had significantly more sharp

    Jason et al. Page 13

    J Behav Neurosci Res. Author manuscript; available in PMC 2011 January 18.

    NIH-PAA

    uthorManuscript

    NIH-PAAuthorManuscript

    NIH-PAAuthor

    Manuscript

  • 8/3/2019 Chronic Fatigue and Kindling

    14/24

    waves, more frequent high amplitude alpha, and more frequent bursts of theta waves in the

    posterior regions. In the patients with ME/CFS, abnormalities were observed that involved

    high amplitude sharp alpha rhythm (10 Hz) that occurs in the occipital lobes upon closing

    the eyes. Also, discharges of the type one associates with epilepsy were seen in the temporal

    lobes. These are typically found after head injury and extreme sleep deprivation, also

    occurring after kindling. Temporal lobes have a predilection for infection by the herpes virus

    in acute herpes encephalopathy and encephalitis; therefore, the findings might be related to

    post-viral mild encephalopathy affecting primarily the temporal lobes, which could causethe self-reported memory and attention problems. In a later study, Duffy et al. (2009) found

    that factors derived from the EEG data were able to discriminate with nearly 90% accuracy

    patients with ME/CFS from healthy controls and from those with major depression.

    Discussion

    Findings reviewed in this article suggest that for some patients with ME/CFS, kindling

    might lead to oxidative stress through increased activation of NMDA receptors. Kindling

    might appear after prolonged stimulation of the limbic-hypothalamic-pituitary axis, either by

    high-intensity stimulation (e.g., brain trauma) or by chronically repeated low-intensity

    stimulation (e.g., an infectious illness). In support of kindling theory, there is evidence of

    changes in ion transport and ion channel activity (Gow et al., 2005). Several studies also

    suggest that oxidative stress does occur in patients with ME/CFS (Kennedy et al., 2005;Robinson et al., 2009).

    Some individuals might be at higher risk of developing kindling and chronic activation,

    ultimately leading to oxidative stress. Vollmer-Conna et al. (2008) found that individuals

    with high levels of IFN-gamma (a pro-inflammatory cytokine) and low levels of IL10 (an

    anti-inflammatory cytokine) were significantly more likely to experience severe acute illness

    following infection. In addition, Glass et al. (2004) found that healthy individuals with

    certain biological patterns (i.e., lower cortisol, more heart rate variability, and NK attenuated

    response to stress) developed somatic symptoms when asked to stop exercising for a week.

    Individuals with diminished GABA functioning might also be more likely to develop

    kindling (Doi et al., 2009). These might be some of the predisposing neuroendocrine and

    immunologic irregularities of individuals who are at increased risk for developing ME/CFS.

    It would be of particular importance to study such high risk individuals in longitudinaldesigns.

    Patients with ME/CFS often report prior exposure to a viral infection. Viruses increase

    activation of macrophages, which produce a release of interleukin-1beta, causing an

    alteration in the electrical activity of the brain (Maier, Watkins, & Fleshner, 1994). The

    production of pro-inflammatory cytokines (IL-1b and IL6) is correlated with acute sickness

    behavior (i.e., fever, malaise, pain, fatigue, and poor concentration; Vollmer-Conna et al.,

    2004), and prolonged exposure to these cytokines might induce a state of chronic activation

    and kindling. Kindling and related seizure activity in animal models is associated with

    increased signal transcription and production of pro-inflammatory proteins within the brain

    (Plata-Salaman et al., 2000), and the administration of TNF-alpha not only increases seizure

    activity in an animal kindling model, it may also potentiate the development of future

    activity (Shandra et al., 2002). Elevated levels of pro-inflammatory cytokines can alsoinduce inducible nitric oxide synthase expression, which results in elevated levels of nitric

    oxide. The nitric oxide then reacts with superoxide to form the powerful oxidant

    peroxynitrite. For those individuals who are affected by this activation, oxidative stress

    might be a resultant consequence.

    Jason et al. Page 14

    J Behav Neurosci Res. Author manuscript; available in PMC 2011 January 18.

    NIH-PAA

    uthorManuscript

    NIH-PAAuthorManuscript

    NIH-PAAuthor

    Manuscript

  • 8/3/2019 Chronic Fatigue and Kindling

    15/24

    Viral exposure early in life could trigger an immunologic cascade with significant effects on

    kindling. The release of TNF-alpha and other mediators could contribute to immunologic

    sensitization through inflammation and corticosteroid mediation. This then might leave an

    individual primed to respond in an adverse fashion to a future stressor event through

    amygdala and hippocampal kindling. The response to a stressor event then might reintroduce

    an inflammatory response that could contribute to the development of lesions and

    symptomatology. This could help explain why viral exposure does not necessarily trigger

    immediate symptomatology. It is also more in line with the consensus opinion regardingMS, with early retroviral exposure and the development of disease later in life.

    Areas of the prefrontal cortex and anterior cingulate influence the amygdala (Gupta, 2002),

    and kindling in these areas and others could cause continuous sympathetic stimulation that

    would eventually lead to mental and physical exhaustion as well as glandular depletion.

    Kindling could cause CRH to be released from the paraventricular nucleus of the

    hypothalamus. CRH causes ACTH to be released from the anterior pituitary, and ACTH in

    turn stimulates cortisol release from the adrenal cortex. Exposure to chronic stressors could

    eventually lead to hypocortisolism, which is frequently found among ME/CFS patients,

    along with increased serotonin neurotransmitter function (Cleare et al., 1995).

    Glucocorticoids can have an inhibitory effect on serotonin function, and CRH release is

    modulated by serotonin. There is evidence of elevated activity of presynaptic serotonin

    neurons (Vassallo et al., 2001), and this could be an area affected by kindling. Fries et al.(2005) suggest enhanced pituitary feedback is the primary mechanism underlying the

    hypocortisolemic stress response. Finally, chronic cortisol deficiency can cause an

    overproduction of interleukin-6 (Il-6), which has been associated with symptoms of ME/

    CFS (Arnold et al., 2002). Ejection fraction decreases and lower cardiac output (Peckerman,

    Chemitiganti, et al., 2003) could be due to lowered cortisol (Pall, 2007) as well as an

    overactive sympathetic nervous system.

    As previously mentioned, patients with ME/CFS appear to have a shift from Th1 to Th2

    cytokines (Antoni et al., 2003). In an acutely stressed stage, animal models indicated that at

    first serotonin and dopamine systems are activated in the central nervous system (Tanaka &

    Watanabe, 2007). If kindling were to occur for weeks or months, glucocorticoid levels

    would initially be maintained at a high level, and the immune system would be suppressed,

    which would suppress both inflammation and the Th1 immune response, with a shift to aTh2 immune response. Norepinephrine and epinephrine inhibit the production of type 1/

    proinflammatory cytokines, whereas they stimulate the production of type 2/anti-

    inflammatory cytokines thereby causing a selective suppression of Th1 responses and

    cellular immunity and a Th2 shift (Elenkov, Wilder, Chrousos, & Vizi, 2000). Because of

    the Th2 shift, the body would not have an effective defense against viral or intracellular

    bacterial infections. Eventually, the HPA axis might switch from HPA axis hyper- to

    hypofunctioning (Van Houdenhove, Van Den Eede, & Luyten, 2009). But when the HPA

    axis has become downregulated, there would still not be an effective Th1 response to attack

    the viral infection; however, now the immune system may cause inflammation, explaining

    elevated antinuclear antibody levels (Van Konynenburg, 2003).

    In addition, patients with ME/CFS might have depletion of acetylcholine and increased

    sensitivity of the post-synaptic acetylcholine receptors (Chaudhuri et al., 1997). Kindlingmight also be implicated in this process and it would also cause sympathetic nervous system

    hyperactivity, which may ultimately result in decreased serum cortisol (Kizildere, Gluck,

    Zietz, Scholmerich, & Straub, 2003). Kindling can then be associated with variation in the

    responsiveness of the HPA axis (Weiss, Castillo & Fernandez, 1993) and provide a new lens

    through which to view the frequent finding of hypocortisolism in those with CFS.

    Jason et al. Page 15

    J Behav Neurosci Res. Author manuscript; available in PMC 2011 January 18.

    NIH-PAA

    uthorManuscript

    NIH-PAAuthorManuscript

    NIH-PAAuthor

    Manuscript

  • 8/3/2019 Chronic Fatigue and Kindling

    16/24

    According to Light et al. (2009), there are constant interactions between the sympathetic

    nervous system, the immune system, and the sensory systems in CFS. If patients with CFS

    have enhancement of peripheral sensory signals, due to kindling, and these signals likely

    activate sympathetic nervous system reflexes that normally maintain blood flow to the brain

    and skeletal muscles. Long-term sensory receptor activation can lead to sensitization of

    spinal cord and brain systems that transmit fatigue signals, causing long-term fatigue

    enhancement within the central nervous system (Cook, OConnor, Lange, & Steffener

    2007), Because vascular smooth muscle adrenergic receptors desensitize to the constantrelease of catecholamines (Kaufman & Hayes, 2002), this dysregulation could lead to bouts

    of increased metabolites that would further activate sensory receptors. If there was a large

    number of ASIC3, P2X5 and/or P2X4, and TRPV1 receptors on sensory neurons (Light et

    al., 2009), resting levels of metabolites could activate sensory fatigue afferents, but in

    particular, exercise could send a continuous signal of muscle sensory fatigue to the central

    sympathetic nervous system causing dysregulation of sympathetic nervous system reflexes,

    and ultimately producing the recognition of enhanced fatigue.

    The oxidative stress theory of Pall (2007) implicates nitric oxide production to ultimately

    produce peroxynitrite, and there is some evidence for this model (Kennedy et al., 2005).

    There is also supportive evidence by de Lange et al. (2005) of significant reductions in grey

    matter volume in patients with ME/CFS. But there are conflicting studies specifying where

    the damage is occurring. Johnson and DeLuca (2005) summarize findings indicating thatsome patients have hypometabolism in the frontal lobes and ganglia. Siessmeier et al. (2003)

    found abnormalities in about half the patients with ME/CFS, but no specific pattern could be

    identified (some had hypometabolism bilaterally in the cingulate gyrus and the adjacent

    mesial cortical areas, decreased metabolism in the orbitofrontal cortex, or hypometabolism

    in the cuneus/praecuneus). Others have found alteration in the serotoninergic neurons in the

    anterior cingulate cortex (Yamamoto et al., 2004), widespread reduction in 5-HT(1A)

    receptor binding potential in the hippocampus bilaterally (Cleare, Messa, Rabiner, &

    Grasby, 2005), problems in cerebellar, temporal, cingulate and frontal regions (Cook,

    OConnor, Lange, & Steffener, 2007), and higher delta waves in the left uncus and

    parahippocampal gyrus and higher theta waves in the cingulate gyrus and right superior

    frontal gyrus (Sherlin et al., 2006). Additionally, larger observed activity was found in the

    medial parietal cortex and precuneus in fatigue provoking tasks and lower cerebral activity

    in the dorsolateral prefrontal cortex (Caseras et al., 2008), and abnormalities involving highamplitude sharp alpha rhythm (10 Hz) that occurs in the occipital lobes, and epileptic-like

    discharges in the temporal lobes have been found (Donati, Fagioli, Komaroff, & Duffy,

    1994).

    These discrepant findings could be due to different regions of the brain becoming kindled in

    a secondary way from the initial kindling, and these secondary sites could then affect

    different organ systems and even lead to mitochondrial dysfunction (Myhill, Booth, &

    McLaren-Howard, 2009). These findings support the idea that there might be important

    subtypes among patients with ME/CFS (Corradi, Jason, & Torres-Harding, 2006).

    Ultimately, there is a need for investigators to develop a CFS research network that can

    assemble large carefully defined data sets involving either natural history studies,

    investigations with individuals exposed to challenges (i.e., exercise, orthostatic, mental), or

    pharmacologic or non-pharmacologic interventions. Such large data sets might allow us toultimately identify important subtypes that remain within our samples. Comparing small

    samples with patients possibly having different characteristics (e.g., some studies have all or

    almost all patients with post-exertional malaise whereas others have fewer with this classic

    CFS symptom) might complicate the search for biological markers. Standardization of the

    procedures to collect these types of large data sets represents one of the largest challenges to

    the field.

    Jason et al. Page 16

    J Behav Neurosci Res. Author manuscript; available in PMC 2011 January 18.

    NIH-PAA

    uthorManuscript

    NIH-PAAuthorManuscript

    NIH-PAAuthor

    Manuscript

  • 8/3/2019 Chronic Fatigue and Kindling

    17/24

    One limitation in this review is that we have not evaluated the quality of the work reviewed.

    Given the large number of studies mentioned, it would have been extremely difficult to

    review strengths and weaknesses of each scientific article. By focusing on those articles that

    are most theoretically supportive of the two hypotheses of this paper, we hope to encourage

    researchers to take next steps and focus their research in these areas. We hope that the large

    number of studies cited provide supportive data that might provide a better lens for

    understanding this complex disorder. It is also unclear whether the proposed kindling and

    oxidative stress mechanisms might be operative in all cases of ME/CFS, or that are involvedsingly or in combination, in specific phenotypes only. Future research will be needed to

    explore this topic in more detail.

    It is at least possible that centrally mediated kindling and oxidative stress might lead to

    different types of immune, autonomic, or neuroendocrine dysfunction in different patients.

    Such a theory might also have implications for treatment by helping patients with

    normalization of neuroendocrine-immune functioning (Van Houdenhove et al., 2009; Jason,

    Benton, Torres-Harding, & Muldowney, 2009), external stimulation in the form of a delayed

    feedback (Kim, Roberts, & Robinson, 2009), or in the use of pharmacologic drugs, which

    attenuates central sympathetic outflow (Wyller et al., 2009).

    Acknowledgments

    Requests for reprints should be sent to Leonard A. Jason, DePaul University, Center for Community Research, 990

    W. Fullerton Ave., Chicago, Il. 60614. The authors appreciate the funding provided by NIAID (grant number AI

    49720 and AI 055735).

    References

    Adcock IM, Cosio B, Tsaprouni L, Barnes PJ, Ito K. Redox regulation of histone deacetylases and

    glucocorticoid-mediated inhibition of the inflammatory response. Antioxidants & Redox Signaling

    2005;7:144152. [PubMed: 15650403]

    Altemus M, Dale DK, Michelson D, Demitrack MA, Gold PW, Straus SE. Abnormalities in response

    to vasopressin infusion in chronic fatigue syndrome. Psychoneuroendocrinology 2001;26:175188.

    [PubMed: 11087963]

    Anderson JS, Ferrans CE. The quality of life of persons with chronic fatigue syndrome. Journal of

    Nervous and Mental Disease 1997;185:359367. [PubMed: 9205421]Antoni, MH.; Fletcher, MA.; Weiss, D.; Maher, K.; Siegel, BS.; Klimas, N. Impaired natural and

    heightened lymphocyte activation relate to greater disruptions in patients with CFS; Poster

    presented at the Sixth International Conference on Chronic Fatigue Syndrome, Fibromyalgia, and

    Related Illnesses; Chantilly, Virginia. Feb.. 2003

    Arnold MC, Papanicolaou DA, OGrady JA, Lotsikas A, Dale JK, Straus SE, Grafman J. Using an

    interleukin-6 challenge to evaluate neuropsychological performance in chronic fatigue syndrome.

    Psychological Medicine 2002;32:10751089. [PubMed: 12214788]

    Badawy AB, Morgan CJ, Llewelyn MB, Selwyn RJ, Albuquerque SRJ, Farmer A. Heterogeneity of

    serum tryptophan concentration and availability to the brain in patients with the chronic fatigue

    syndrome. Journal of Psychopharmacology 2005;19:385391. [PubMed: 15982993]

    Bakheit AM, Behan PO, Dinan TG, Gray CE, OKeane V. Possible upregulation of hypothalantic 5-

    hydroxytryptamine receptors in patients with postviral fatigue syndrome. British Medical Journal

    1992;304:10101012. [PubMed: 1586780]Baram TZ, Hatalski CG. Neuropeptide-mediated excitability: A key triggering mechanism for seizure

    generation in the developing brain. Trends in Neuroscience 1998;21:471476.

    Bell IR, Rossi J, Gilbert ME, Kobal G, Morrow LA, Newlin DB, Sorg BA, Wood RW. Testing the

    neural sensitization and kindling hypothesis for illness from low levels of environmental chemicals.

    Environmental Health Perspectives 1997;105(Supplement 2):539547. [PubMed: 9167993]

    Jason et al. Page 17

    J Behav Neurosci Res. Author manuscript; available in PMC 2011 January 18.

    NIH-PAA

    uthorManuscript

    NIH-PAAuthorManuscript

    NIH-PAAuthor

    Manuscript

  • 8/3/2019 Chronic Fatigue and Kindling

    18/24

    Ben-Zvi A, Vernon SD, Broderick G. Model-based therapeutic correction of hypothalamic-pituitary-

    adrenal axis dysfunction. PLoS Computational Biology 2009;5(1):e1000273. doi:10.1371/

    journal.pcbi.1000273. [PubMed: 19165314]

    Bierhaus A, Wolf J, Andrassy M, Rohleder N, Humpert PM, et al. A mechanism converting

    psychosocial stress into mononuclear cell activation. Proceedings of the National Academy of

    Sciences of the United States of America 2003;100:19201925. [PubMed: 12578963]

    Billiot KM, Budzynski TH, Andrasik F. EEG patterns and chronic fatigue syndrome. Journal of

    Neurotherapy 1997;2(2):2030. available at http://www.snr-jnt.org/JournalNT/JNT(2-2)4.html.

    Borish L, Schmaling K, DiClementi J, Streib J, Negri J, Jones JF. Chronic fatigue syndrome:

    Identification of distinct subgroups on the basis of allergy and psychologic variables. Journal of

    Allergy and Clinical Immunology 1998;102(2):222230. [PubMed: 9723665]

    Brouwer B, Packer T. Corticospinal excitability in patients diagnosed with Chronic Fatigue Syndrome.

    Muscle and Nerve 1994;17:12101212. [PubMed: 7935529]

    Buchwald D, Pearlman T, Umali J, Schmaling K, Katon W. Functional status in patients with chronic

    fatigue syndrome, other fatiguing illnesses, and healthy individuals. American Journal of Medicine

    1996;101:364370. [PubMed: 8873506]

    Caseras X, Mataix-Cols D, Rimes KA, Giampietro V, Brammer M, Zelaya F, Chalder T, Godfrey E.

    The neural correlates of fatigue: An exploratory imaginal fatigue provocation study in chronic

    fatigue syndrome. Psychological Medicine 2008;38:941951. [PubMed: 18447963]

    Chaudhuri A, Behan PO. Fatigue in neurological disorders. The Lancet 2004;363:978988.

    Chaudhuri, A.; Behan, PO.; Behan, WMH. Ion channel function and chronic fatigue syndrome; Paperpresented at the International Conference on Fatigue Science; Karuizawa, Japan. Feb.. 2005

    Chaudhuri A, Majeed T, Dinan T, Behan PO. Chronic Fatigue Syndrome: A disorder of central

    cholinergic transmission. Journal of Chronic Fatigue Syndrome 1997;3:316.

    Clauw DJ, Chrousos GP. Chronic pain and fatigue syndromes: Overlapping clinical and

    neuroendocrine features and potential pathogenic mechanisms. Neuroimmunomodulation

    1997;4:134153. [PubMed: 9500148]

    Cleare AJ, Bearn J, Allain T, McGregor A, Wessely S, Murray RM, OKeane V. Contrasting

    neuroendocrine responses in depression and chronic fatigue syndrome. Journal of Affective

    Disorders 1995;34:283289. [PubMed: 8550954]

    Cleare AJ, Messa C, Rabiner EA, Grasby PM. Brain 5-HT1A receptor binding in chronic fatigue

    syndrome measured using positron emission tomography and [11C]WAY-100635. Biological

    Psychiatry 2005;57(3):239246. [PubMed: 15691524]

    Cook DB, Lange G, DeLuca J, Natelson BH. Relationship of brain MRI abnormalities and physicalfunctional status in chronic fatigue syndrome. InternationalJournal of Neuroscience 2001;107:1

    6. [PubMed: 11328679]

    Cook DB, OConnor PJ, Lange G, Steffener J. Functional neuroimaging correlates of mental fatigue

    induced by cognition among chronic fatigue syndrome patients and controls. NeuroImage

    2007;36(1):108122. [PubMed: 17408973]

    Corradi, KM.; Jason, LA.; Torres-Harding, SR. Exploratory subgrouping in CFS: Infectious,

    inflammatory, and other. In: Columbus, A., editor. Advances in Psychology Research. Vol.

    Volume 41. Nova Science Publishers; Hauppauge, N. Y.: 2006. p. 115-127.

    de Lange FP, Koers A, Kalkman JS, Bleijenberg G, Hagoort P, van der Meer JW, Toni I. Increase in

    prefrontal cortical volume following cognitive behavioural therapy in patients with chronic fatigue

    syndrome. Brain 2008;131:21722180. [PubMed: 18587150]

    de Lange FP, Knoop H, Bleijenberg G, van der Meer JW. The experience of fatigue in the brain (Letter

    to the Editor). Psychological Medicine 2008;38:523524. Published online. doi:10.1017/

    S0033291708004844. [PubMed: 17903334]

    de Lange FP, Kalkman JS, Bleijenberg G, Hagoort P, van der Meer JWM, Toni I. Gray matter volume

    reduction in the chronic fatigue syndrome. NeuroImage 2005;26:777781. [PubMed: 15955487]

    Demitrack MA, Gold PW, Dale JK, Krahn DD, Kling MA, Straus SE. Plasma and cerebrospinal fluid

    monoamine metabolism in patients with chronic fatigue syndrome: preliminary findings. Biology

    and Psychiatry 1992;32:10661077.

    Jason et al. Page 18

    J Behav Neurosci Res. Author manuscript; available in PMC 2011 January 18.

    NIH-PAA

    uthorManuscript

    NIH-PAAuthorManuscript

    NIH-PAAuthor

    Manuscript

    http://www.snr-jnt.org/JournalNT/JNT(2-2)4.html
  • 8/3/2019 Chronic Fatigue and Kindling

    19/24

    Donati, F.; Fagioli, L.; Komaroff, AL.; Duffy, FH. Quantified EEG findings in patients with chronic

    fatigue syndrome; Paper presented at the American Association for Chronic Fatigue Syndrome; Ft.

    Lauderdale, Florida. Oct.. 1994

    Doi T, Ueda Y, Nagatomo K, Willmore LJ. Role of Glutamate and GABA Transporters in

    development of Pentylenetetrazol-Kindling. Neurochemistry Research 2009;34(7):13241331.

    DOI 10.1007/s11064-009-9912-0.

    Duffy, FH.; McAnulty, GB.; McCreary, M.; Albert, MS.; Cucharal, G.; Shatzberg, AF.; Komaroff,

    AL. Electroencephalographic data distinguish patients with CFS from healthy and depressed

    controls; Paper presented at the 9th International Association of CFS/ME; Reno, NV. Mar. 2009

    Dusek JA, Otu HH, Wohlhueter AL, Bhasin M, Zerbini LF, Joseph MG, et al. Genomic counter-stress

    changes induced by the relaxation response. PLoS ONE 2008;3(7):e2576. doi:10.1371/

    journal.pone.0002576. [PubMed: 18596974]

    Elenkov IJ, Wilder RL, Chrousos GP, Vizi ES. The sympathetic nerveAn integrative interface

    between two supersystems: The brain and the immune system. Pharmacological Reviews

    2000;52:595638. [PubMed: 11121511]

    Englebienne, P.; Meirleir, KD. Chronic fatigue syndrome: A biological approach. CRC Press; Boca

    Raton: 2002.

    Evengard B, Schachterle RS, Komaroff AL. Chronic fatigue syndrome: New insights and old

    ignorance. Journal of Internal Medicine 1999;246:455469. [PubMed: 10583715]

    Forte P, Kneale BJ, Milne E, Chowienczyk PJ, Johnston A, Benjamin N, Ritter JM. Evidence for a

    difference in nitric oxide biosynthesis between healthy women and men. Hypertension

    1998;32:730734. [PubMed: 9774371]

    Friedberg, F.; Jason, LA. Understanding chronic fatigue syndrome: An empirical guide to assessment

    and treatment. American Psychological Association; Washington, D.C.: 1998.

    Fries E, Hesse J, Hellhammer J, Hellhammer DH. A new view on hypocortisolism.

    Psychoneuroendocrinology 2005;30(10):10101016. [PubMed: 15950390]

    Gellhorn E. The emotions and the ergotropic and trophotropic systems. Psychologische Forschung

    1970;34:4894. [PubMed: 4929035]

    Girdano, DA.; Everly, GS., Jr.; Dusek, DE. Controlling stress and tension. A holistic approach.

    Prentice Hall; Englewood Cliffs, N.J.: 1990.

    Glass JM, Lyden AK, Petzke F, Stein P, Whalen G, Ambrose K, Chrousos G, Clauw DJ. The effect of

    brief exercise cessation on pain, fatigue, and mood symptom development in healthy, fit

    individuals. Journal ofPsychosomatic Research 2004;57:391398. [PubMed: 15518675]

    Goddard GV. Development of epileptic seizures through brain stimulation at low intensity. Nature1967;214:10201021. [PubMed: 6055396]

    Gow, JW.; Cannon, C.; Behan, WMH.; Herzyk, P.; Keir, S.; Riboldi-Tunnicliffe, G.; Behan, PO.;

    Chaudhuri, A. Whole-genome (33,000 genes) affymetrix DNA microarray analysis of gene

    expression in chronic fatigue syndrome; Paper presented at the International Conference on

    Fatigue Science; Karuizawa, Japan. Feb. 2005

    Gray RT, Robinson PA. Stability and spectra of randomly connected excitatory cortical networks.

    Neurocomputing 2007;70:10001012.

    Gupta A. Unconscious amygdalar fear conditioning in a subset of chronic fatigue syndrome patients.

    Medical Hypotheses 2002;59:727735. [PubMed: 12445517]

    Gupta A, Vij G, Sharma S, Tirkey N, Rishi P, Chopra K. Curcumin, a polyphenolic antioxidant,

    attenuates chronic fatigue syndrome in murine water immersion stress model. Immunobiology

    2009;214:3339. [PubMed: 19159825]

    Halassa MM, Florian C, Fellin T, Munoz JR, Lee S-Y, Abel T, Haydon P, Frank MG. Astrocyticmodulation of sleep homeostasis and cognitive consequences of sleep loss. Neuron 2009;61:213

    219. [PubMed: 19186164]

    Hausler M, Ramaekers VT, Doenges M, Schweizer K, Ritter K, Schaade L. Neurological

    complications of acute and persistent Epstein-Barr Virus infection in paediatric patients. Journal of

    Medical Virology 2002;68:253263. [PubMed: 12210416]

    Heinrichs SC, Koob GF. Corticotropin-releasing factor in brain: A role in activation, arousal, and

    affect regulation. Perspectives in Pharmacology 2004;311:427440.

    Jason et al. Page 19

    J Behav Neurosci Res. Author manuscript; available in PMC 2011 January 18.

    NIH-PAA

    uthorManuscript

    NIH-PAAuthorManuscript

    NIH-PAAuthor

    Manuscript

  • 8/3/2019 Chronic Fatigue and Kindling

    20/24

    Hickie I, Davenport T, Wakefield D, Vollmer-Conna U, Cameron B, Vernon SD, Reeves WC, Lloyd

    A. Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens:

    prospective cohort study. British Medical Journal 2006;333(7568):575578. doi:10.1136/bmj.

    38933.585764.AE. [PubMed: 16950834]

    Hong ZY, Huang ZL, Qu WM, Eguchi N, Urade Y, Hayaishi O. An adenosine A receptor agonist

    induces sleep by increasing GABA release in the tuberomammillary nucleus to inhibit

    histaminergic systems in rats. Journal of Neurochemistry 2005;92:15421549. [PubMed:

    15748171]

    Inoue, K.; Fushiki, T. Exercise fatigue. In: Watanabe, Y.; Evengard, B.; Natelson, BH.; Jason, LA.;

    Kuratsune, H., editors. Fatigue Science for Human Health. Springer; Tokyo: 2007. p. 187-201.

    Ito K, Lim S, Caramori G, Chung KF, Barnes PJ, Adcock IM. Cigarette smoking reduces histone

    deacetylase 2 expression, enhances cytokine expression, and inhibits glucocorticoid actions in

    alveolar macrophages. The FASEB Journal 2001;15:11101112. [PubMed: 11292684]

    Jason LA, Benton M, Torres-Harding S, Muldowney K. The impact of energy modulation on physical

    functioning and fatigue severity among patients with ME/CFS. Patient Education and Counseling

    2009;77(2):237241. doi:10.1016/j.pec.2009.02.015. [PubMed: 19356884]

    Jason LA, Benton M, Johnson A, Valentine L. The economic impact of ME/CFS: Individual and

    societal level costs. Dynamic Medicine. 2008 7:6. doi:10.1186/1476-5918-7-6. http://

    www.dynamic-med.com/content/7/1/6. [PubMed: 18397528]

    Jason LA, Richman JA, Rademaker AW, Jordan KM, Plioplys AV, Taylor RR. A community-based

    study of Chronic Fatigue Syndrome. Archives of Internal Medicine 1999;159:21292137.

    [PubMed: 10527290]

    Johnson, SK.; DeLuca, J. Chronic fatigue syndrome and the brain. In: DeLuca, J., editor. Fatigue as a

    window to the brain. MIT Press; Cambridge, MA: 2005. p. 137-156.

    Kaufman MP, Hayes SG. The exercise pressor reflex. Clinical Autonomic Research 2002;12:429439.

    [PubMed: 12598947]

    Kennedy G, Spence VA, McLaren M, Hill A, Underwood C, Belch J. Oxidative stress levels are raised

    in chronic fatigue syndrome and are associated with clinical symptoms. Free Radical Biology &

    Medicine 2005;39:584589. [PubMed: 16085177]

    Kerr JR, Petty R, Burke B, Gough J, Fear D, Sinclair LI, Mattey DL, Richards SC, Montgomery J,

    Baldwin DA, Kellam P, Harrison TJ, Griffin GE, Main J, Enlander D, Nutt DJ, Holgate ST. Gene

    expression subtypes in patients with chronic fatigue syndrome/myalgic encephalomyelitis. Journal

    of Infectious Diseases 2008;197:11711184. [PubMed: 18462164]

    Kim JW, Roberts JA, Robinson PA. Dynamics of epileptic


Recommended